BACKGROUND: Previous studies have found no association between graft ischemic time (IT) and survival in pediatric heart transplant (HTx) recipients. However, previous studies were small or analyzed risk only at the extremes of IT, where observations are few. We sought to determine whether graft IT is independently associated with graft survival in a large cohort of children with no a priori assumptions about where the risk threshold may lie. METHODS: All children aged <18 years in the U.S. undergoing primary HTx (1987 to 2008) were included. The primary end point was graft loss (death or retransplant) within 6 months. Multivariate analysis was performed to analyze the association between graft IT and graft loss within 6 months after transplant. A secondary end point of longer-term graft loss was assessed among recipients who survived the first 6 months after transplant. RESULTS: Of 4,716 pediatric HTxs performed, the median IT was 3.5 hours (interquartile range, 2.7-4.3 hours). Adjusted analysis showed that children with an IT > 3.5 hours were at increased risk of graft loss within 6 months after transplant (hazard ratio, 1.3; 95% confidence interval, 1.1-1.5; p = 0.002). Among 6-month survivors, IT was not associated with longer-term graft loss. CONCLUSIONS: IT beyond 3.5 hours is associated with a 30% increase in risk of graft loss within 6 months in pediatric HT recipients. Although the magnitude of risk associated with IT is small compared with the risk associated with recipient factors, these findings may be important during donor assessment for high-risk transplant candidates. 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
BACKGROUND: Previous studies have found no association between graft ischemic time (IT) and survival in pediatric heart transplant (HTx) recipients. However, previous studies were small or analyzed risk only at the extremes of IT, where observations are few. We sought to determine whether graft IT is independently associated with graft survival in a large cohort of children with no a priori assumptions about where the risk threshold may lie. METHODS: All children aged <18 years in the U.S. undergoing primary HTx (1987 to 2008) were included. The primary end point was graft loss (death or retransplant) within 6 months. Multivariate analysis was performed to analyze the association between graft IT and graft loss within 6 months after transplant. A secondary end point of longer-term graft loss was assessed among recipients who survived the first 6 months after transplant. RESULTS: Of 4,716 pediatric HTxs performed, the median IT was 3.5 hours (interquartile range, 2.7-4.3 hours). Adjusted analysis showed that children with an IT > 3.5 hours were at increased risk of graft loss within 6 months after transplant (hazard ratio, 1.3; 95% confidence interval, 1.1-1.5; p = 0.002). Among 6-month survivors, IT was not associated with longer-term graft loss. CONCLUSIONS: IT beyond 3.5 hours is associated with a 30% increase in risk of graft loss within 6 months in pediatric HT recipients. Although the magnitude of risk associated with IT is small compared with the risk associated with recipient factors, these findings may be important during donor assessment for high-risk transplant candidates. 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Authors: D F Del Rizzo; A H Menkis; P W Pflugfelder; R J Novick; F N McKenzie; W D Boyd; W J Kostuk Journal: J Heart Lung Transplant Date: 1999-04 Impact factor: 10.247
Authors: Mark J Russo; Jonathan M Chen; Robert A Sorabella; Timothy P Martens; Mauricio Garrido; Ryan R Davies; Isaac George; Faisal H Cheema; Ralph S Mosca; Seema Mital; Deborah D Ascheim; Michael Argenziano; Allan S Stewart; Mehmet C Oz; Yoshifumi Naka Journal: J Thorac Cardiovasc Surg Date: 2007-02 Impact factor: 5.209
Authors: Jeffrey A Morgan; Ranjit John; Yookyung Park; Linda J Addonizio; Mehmet C Oz; Niloo M Edwards; Jan M Quaegebeur; Ralph S Mosca Journal: J Heart Lung Transplant Date: 2005-01 Impact factor: 10.247
Authors: Christopher S D Almond; Ravi R Thiagarajan; Gary E Piercey; Kimberlee Gauvreau; Elizabeth D Blume; Heather J Bastardi; Francis Fynn-Thompson; T P Singh Journal: Circulation Date: 2009-01-26 Impact factor: 29.690
Authors: Silvana F Marasco; Donald S Esmore; Meroula Richardson; Michael Bailey; Justin Negri; Michael Rowland; David Kaye; Peter J Bergin Journal: Clin Transplant Date: 2007 May-Jun Impact factor: 2.863
Authors: Ryan R Davies; Mark J Russo; Seema Mital; Timothy M Martens; Robert S Sorabella; Kimberly N Hong; Annetine C Gelijns; Alan J Moskowitz; Jan M Quaegebeur; Ralph S Mosca; Jonathan M Chen Journal: J Thorac Cardiovasc Surg Date: 2007-11-26 Impact factor: 5.209
Authors: Nicholas R Banner; Helen L Thomas; Elinor Curnow; Julie C Hussey; Chris A Rogers; Robert S Bonser Journal: Transplantation Date: 2008-08-27 Impact factor: 4.939
Authors: Don Hayes; Robert S Higgins; Ahmet Kilic; Stephen Kirkby; Amy L Pope-Harman; Thomas J Preston; Bryan A Whitson Journal: Lung Date: 2014-05-10 Impact factor: 2.584
Authors: Benjamin J Kopecky; Christian Frye; Yuriko Terada; Keki R Balsara; Daniel Kreisel; Kory J Lavine Journal: Am J Transplant Date: 2020-01-29 Impact factor: 8.086
Authors: Alia Dani; Quyen Vu; Karthik Thangappan; Bin Huang; Samuel Wittekind; Angela Lorts; Clifford Chin; David L S Morales; Farhan Zafar Journal: Pediatr Transplant Date: 2022-03-08
Authors: Tajinder P Singh; Eileen Hsich; Wida S Cherikh; Daniel C Chambers; Michael O Harhay; Don Hayes; Kiran K Khush; Luciano Potena; Aparna Sadavarte; Andreas Zuckermann; Josef Stehlik Journal: J Heart Lung Transplant Date: 2020-07-24 Impact factor: 10.247
Authors: Son Q Duong; Justin Godown; Jonathan H Soslow; Cary Thurm; Matt Hall; Sandeep Sainathan; Victor O Morell; Debra A Dodd; Brian Feingold Journal: J Thorac Cardiovasc Surg Date: 2018-11-16 Impact factor: 5.209